DMD clinical studies evolve with emphasis on building designs around relevant endpoints

Though progress is being made in an indication with no known cure and only a handful of treatments, the recent wave of high-profile clinical studies in Duchenne muscular dystrophy (DMD) indicates that choosing the right trial endpoint remains an evolving paradigm.